Migraine Drugs Market Likely to Expand at a Lackluster CAGR of 3.5% by 2025

Posted on 2018-01-05 by Mark Hub in Internet & Online // 0 Comments

Albany, USA, 2018-Jan-05 — /EPR Network/ —Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Migraine Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”

Click here For Free Sample Report @ https://www.mrrse.com/sample/3692

The global migraine drugs market has considerable room for growth in the absence of a permanent cure for the condition and growing genericization of drugs. Hence, established companies in the market are seen upping allocations on research and development to come up with better drugs to satisfy the unmet demands, and thereby grow their sales and revenues. In the upcoming years, the market is expected to see entry of aspiring players too. All these will help to increase competition.

Migraine is a common occurrence worldwide. Hence, with the increasing global population, particularly female population – who are more prone to have migraine, the market for the drugs will likely rise at a steady pace. Posing a challenge to the market, on the downside, is the easy availability of generics and over reliance on over the counter (OTC) pain killers and other drugs in emerging and under developed markets.

As per a report by Market Research Report Search Engine, the global migraine drugs market will likely expand at a lackluster CAGR of 3.5% during the period between 2017 and 2025 to become worth US$3.72 bn by 2025 from US$2.72 bn in 2016.

For More Info, Read Complete Report With Table of Content @ https://www.mrrse.com/sample/3692

Triptans Make Abortive Treatment Segment Dominant

Depending upon the available treatments, the global market for migraine drugs can be divided into abortive treatment and prophylactic treatment. The abortive treatment can be further segmented into triptans, ergot alkoids, etc. The prophylactic treatment segment can be further divided into botulinum toxin, topiramate, etc. At present, the segment of abortive treatment leads the market with a higher share. The triptans are primarily powering the growth of the segment. The segment of prophylactic treatment is also expected to see steady growth in the next couple of years on the back of topiramate, which will likely rise at 3.4% CAGR in the forecast period. Increasing incidences of chronic migraine and rise in inclination towards prophylactic treatment of migraine is projected to fuel this growth.

Depending upon the route of administration, global migraine drugs market can again be classified into injectable, oral, and others including nasal sprays, transdermal patches, etc. Of them, oral route of administration accounts for a dominant share in the market because of their relatively cheaper price and easy availability of orally administrable drugs, namely triptans and topiramate.

Greater Healthcare Expenditure Propels North America Market to Fore

Geographically, North America currently runs the show in the global migraine drugs market. In future too, it is predicted to retain its leading share by rising at a CAGR of 3.4% from 2017 to 2025 to clock a revenue of US$2.13 bn by 2025-end. Factors pushing the market in the region to the fore are greater healthcare expenditure, rising occurrence of migraine, and availability of specialty migraine drugs. Europe trails North America in terms of market share and is forecasted to pull in a revenue to the tune of US$741.4 mn by 2025 by rising at a CAGR of 3.4% from 2017 to 2025.

Vis-à-vis growth rate, Asia Pacific is projected to surpass all other regions by registering a CAGR of 3.8% in the forecast period on the back of growing healthcare expenditure and shift of focus by key players in emerging markets in India and China.

Enquire About this Report @ https://www.mrrse.com/sample/3692

About Market Research Reports Search Engine (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Matched content

Editor’s pick